Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2011 Results
Date:8/4/2011

ax provision

(1,250)7,437(8,687)-117%Tax provision (benefit)

(45)5,268(5,313)-101%Net income (loss)

(1,205)1,809(3,014)-167%Diluted net income (loss) per share

$
(0.04)$
.06$
(0.10)-167%Second Quarter 2011 Key Financial Figures(1) Three Months Ended June 30March 31(in thousands, except per share amounts)

20112011  Change ($)Change (%)Total revenues

$
7,430$
7,501$
(71)-1%Research & development  expenses

5,9994,2671,73241%General & administrative expenses

2,5722,858(286)-10%Non-cash stock-based compensation(2)

1,3251,604(279)-17%Income (loss) before tax provision

(1,392)142(1,534)NATax provision (benefit)

(51)6(57)NANet income (loss)

(1,341)136(1,477)NADiluted net income (loss) per share

$
(0.05)$
.00$
(0.05)NASelect Cash Flow Data(1)
 (in thousands)

 Six Months Ending June 30June 3020112010Net cash provided by (used in)Operating activities

(8,883)(728)Investing activities

16,710(61,311)Financing activities

-2,395Net change in cash and cash equivalents

$
7,827$
(59,644)Select Balance Sheet Data(1) June 30March 31June 30(in thousands)

201120112010Total cash and marketable securities

$
88,399$
94,555$
207,117(1) Unaudited

(2) Non-cash stock-based compensation is allocated to both Research & development and General & administrative expenses OPERATIONAL HIGHLIGHTS   Fanapt® prescriptions, as reported by IMS, reached 30,000 in the second quarter of 2011.  This represents a 17% increase over first quarter 2011 prescriptions.  Since its launch in January 2010, over 110,000 Fanapt® prescriptions have been written in the U.S.

Vanda continues its effort to expand the availability of Fanapt® to markets outside the U.S. and Canada.  On July 22, 2011, the European Me
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... commands the vital signs monitoring devices market with over ... . The North American and European vital signs monitors ... million, respectively, by the end of 2013. They have ... number of elderly people across these economies. The European ... owing to the rising demand for home health patient ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 /PRNewswire/ ... report is available in its catalogue: ... 2014 http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html ... H2, 2014 Summary GlobalData,s clinical ... Review, H2, 2014" provides data on the Acute ...
(Date:9/2/2014)...   Santa Clara dentist , Dr. Alan ... Invisalign. Invisalign is an orthodontic system that uses clear ... the orthodontic treatment of choice for older teens and ... For a limited time, patients can try Invisalign for ... usual cost. This offer cannot be combined, and some ...
Breaking Medicine Technology:Market of Vital Signs Monitoring Devices Forecast to 2018 2Market of Vital Signs Monitoring Devices Forecast to 2018 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2
... , HAMBURG , Feb. 3 ... Wound Therapy (NPWT) will assemble this week to develop a ... NPWT Expert Panel is drafting recommendations for a range of ... published clinical evidence.  Where published evidence is insufficient, the Panel ...
... Feb. 2 Celsis In Vitro, Inc. (Celsis IVT) ... XenoTech LLC, Sekisui Chemical Co. Ltd., and Sekisui Medical Co. Ltd. ... Illinois in Chicago .  XenoTech and Sekisui Medical ... processes and methods performed by XenoTech associated with its in ...
Cached Medicine Technology:International NPWT Expert Panel Convenes in Hamburg 2International NPWT Expert Panel Convenes in Hamburg 3Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 2Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui 3
(Date:9/2/2014)... September 03, 2014 Recently, Top ... hosting companies and announced that JustHost ( http://www.justhost.com/track/seohosts ... the webmasters. , “The hosting suppliers we recommend ... their competitors on hosting features, uptime and server ... 10 Best SEO Hosting says. “We believe that ...
(Date:9/2/2014)... TCG, a leading government technology strategy and ... of the fastest-growing companies in America for the seventh year ... previously recognized in 2013, 2012, 2011, 2010, 2009, 2008, and ... 86% from 2010 to 2013, ranking the company at position ... America - up 635 spots from 2013! More information is ...
(Date:9/2/2014)... Cloud Medical Doctor Software Corporation (Cloud-MDs) ... Practice Business Operations solutions and Billing Services for the ... solutions for all industries announced today that its CEO ... of the CME in Chicago by PRICE Futures Group ... are very proud of the recognition that our CipherLoc ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The Wm. Jennings ... fair and public town hall meeting for Veterans and their ... at the outreach fair to provide Veterans with valuable healthcare ... “The town hall will provide a forum where we can ... programs.” , The outreach fair will be held 4:45 p.m. ...
(Date:9/2/2014)... -- Complications are rare among breast cancer patients ... indicates. However, the researchers did find that ... higher risk for certain complications than a single ... breast cancer patients who had a single (64 ... and were followed for 30 days after surgery. ...
Breaking Medicine News(10 mins):Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2
... and $13.5 Billion in Economic ActivitySACRAMENTO, Calif., April 7 ... part of the state,s economy, generating 130,000 jobs and ... a report released today by the California ... the Taylor Feldman Group, an outside consulting firm with ...
... tied to a retinal disorder, study finds , , TUESDAY, ... drugs called glitazones are associated with an increased risk ... which features swelling and fluid accumulation in the retina. ... that includes medicines such as pioglitazone (Actos) and rosiglitazone ...
... the opinions of African American employees GAITHERSBURG, Md., April 7 ... food and facilities management services company, "allows me to be ... a woman and have a voice in the company," said ... for Health Care Services and chair of the African American ...
... ST. LOUIS, Missouri, April 7 , ... Testing and Remediation Product Suite , ... scientific, technical and,medical information products and services, announced ... Software, Inc. (PDS), the provider of,Softwarefornurses.com online learning ...
... MedPredict,s Rheumatology Thought Leader Panel Creates a ... MedPredict Market Research, a global provider ... has published a new report providing critical ... in the market for rheumatology therapies, including ...
... IL, April 7, 2009) Managing pain in the ICU ... team. However, new reports suggest that taking a comprehensive approach ... in the ICU and even decreasing the incidence of preventable ... CHEST , the peer-reviewed journal of the American College of ...
Cached Medicine News:Health News:California Health Plans Vital to State's Economy 2Health News:Certain Diabetes Drugs May Pose Eye Risk 2Health News:Sodexo Named as One of the Top Three Companies for African Americans on 2009 DiversityInc Top Ten Companies List 2Health News:Elsevier Acquires Professional Development Software, Inc., Provider of 'Software for Nurses' Online Learning Education 2Health News:New Report Defines Challenges for New Entrants in Key Rheumatology Markets 2Health News:'Pain in the ICU' report suggests comprehensive approach 2Health News:'Pain in the ICU' report suggests comprehensive approach 3
Forceps, delicate, straight....
Jewelers Forceps, standard, straight....
1 mm x 6 mm oval hole....
Jewelers forceps. Insulated....
Medicine Products: